2019 Alzheimer’s disease facts and figures.

Cited by (1,017)

Items 601–700 of 1,017

1. Molecular Docking and Recent Advances in the Design and Development of Cholinesterase Inhibitor Scaffolds: Coumarin Hybrids
   Aso Hameed Hasan, Syazwani Itri Amran, Faiq H. S. Hussain, Baram Ahmed Jaff, Joazaizulfazli Jamalis · 2019 · ChemistrySelect
2. Simulation learning to train healthcare students in person-centered dementia care
   Kylie Meyer, Debbie James, Braulio Amezaga, Carole L. White · 2020 · Gerontology & Geriatrics Education
3. Evaluation of Naturalistic Driving Behavior Using In-Vehicle Monitoring Technology in Preclinical and Early Alzheimer’s Disease
   Jennifer Duncan Davis, Ganesh Muneshwar Babulal, George D. Papandonatos, Erin M Burke, Christopher B. Rosnick, Brian R. Ott, Catherine M. Roe · 2020 · Frontiers in Psychology
4. The role of sex and gender in the selection of Alzheimer patients for clinical trial pre-screening
   Maitée Rosende‐Roca, Carla Abdelnour Ruiz, Ester Esteban, Juan Pablo Tartari, Emilio Alarcón‐Martín, Juliana Martínez‐Atienza, Antonio González‐Pérez, María Eugenia Sáez, Asunción Lafuente, Mar Buendía et al. · 2021 · Alzheimer s Research & Therapy
5. New 3-O-substituted xanthone derivatives as promising acetylcholinesterase inhibitors
   Zi Han Loh, Huey Chong Kwong, Kok Wai Lam, Soek Sin Teh, Gwendoline Cheng Lian Ee, Ching Kheng Quah, Anthony Siong Hock Ho, Siau Hui Mah · 2021 · Journal of Enzyme Inhibition and Medicinal Chemistry
6. Artificial intelligence and leukocyte epigenomics: Evaluation and prediction of late-onset Alzheimer’s disease
   Ray O Bahado-Singh, Sangeetha Vishweswaraiah, Buket Aydas, Ali Yılmaz, Raghu Prasad Rao Metpally, David J. Carey, Richard C. Crist, Wade H. Berrettini, George David Wilson, Khalid Imam et al. · 2021 · PLoS ONE
7. Development of grape polyphenols as multi-targeting strategies for Alzheimer's disease
   Farida El Gaamouch, Kalena Liu, Hsiao‐Yun Lin, Clark Wu, Jun Wang · 2021 · Neurochemistry International
8. Emerging insights into the role of albumin with plasma exchange in Alzheimer’s disease management
   Montserrat Costa, Antonio Páez · 2021 · Transfusion and Apheresis Science
9. Neighborhood cognitive amenities? A mixed-methods study of intellectually-stimulating places and cognitive function among older Americans
   Jessica Finlay, Wenshan Yu, Philippa J Clarke, Mao Li, Suzanne E. Judd, Michael H. Esposito · 2021 · Wellbeing Space and Society
10. Differences in Alzheimer’s Disease and Related Dementias Pathology Among African American and Hispanic Women: A Qualitative Literature Review of Biomarker Studies
    Sarah K. Royse, Ann D. Cohen, Beth Ellen Snitz, Caterina Rosano · 2021 · Frontiers in Systems Neuroscience
11. Helicobacter pylori infection and risk for developing dementia: an evidence-based meta-analysis of case-control and cohort studies
    Nanyang Liu, Jiahui Sun, Xuefan Jiang, Hao Li · 2021 · Aging
12. Posttranscriptional regulation of Nrf2 through miRNAs and their role in Alzheimer's disease
    Ravinder Kumar Kaundal, Ashok Kumar Datusalia, Shyam Sundar Sharma · 2021 · Pharmacological Research
13. Cerebral microvascular endothelial glycocalyx damage, its implications on the blood–brain barrier and a possible contributor to cognitive impairment
    Patrice Stoddart, Simon C. Satchell, Raina Devi Ramnath · 2022 · Brain Research
14. Alzheimer's disease and related dementias and heart failure: A community study
    Sheila M. Manemann, David S. Knopman, Jennifer L. St. Sauver, Suzette J. Bielinski, Alanna M. Chamberlain, Susan A. Weston, Ruoxiang Jiang, Veronique Lee Roger · 2022 · Journal of the American Geriatrics Society
15. Risk of Developing Alzheimer’s Disease and Related Dementias in Association with Cardiovascular Disease, Stroke, Hypertension, and Diabetes in a Large Cohort of Women with Breast Cancer and with up to 26 Years of Follow-Up
    Xianglin L. Du, Lulu Song, Paul Ernest Schulz, Hua Xu, Wenyaw Chan · 2022 · Journal of Alzheimer s Disease
16. Sleep Signal Analysis for Early Detection of Alzheimer's Disease and Related Dementia (ADRD)
    Somayeh Khosroazad, Ali Abedi, Marie J. Hayes · 2023 · IEEE Journal of Biomedical and Health Informatics
17. EEG Entropy in REM Sleep as a Physiologic Biomarker in Early Clinical Stages of Alzheimer’s Disease
    Hamed Azami, Sebastián Moguilner, Héctor Penagos, Rani A. Sarkis, Steven Edward Arnold, Stephen N. Gomperts, Alice D. Lam · 2023 · Journal of Alzheimer s Disease
18. Cultural and Social Factors in Care Delivery Among African American Caregivers of Persons With Dementia: A Scoping Review
    Idorenyin Imoh Udoh, Charity Tinofirei · 2023 · Gerontology and Geriatric Medicine
19. Attention-based and micro designed EfficientNetB2 for diagnosis of Alzheimer’s disease
    Hejie Li, Ying Hui Valerie Tan, Jiaqing Miao, Ping Liang, Jinnan Gong, Hui He, Yuhong Jiao, Fan Zhang, Yaolin Xing, Donghan Wu · 2023 · Biomedical Signal Processing and Control
20. Circadian control of heparan sulfate levels times phagocytosis of amyloid beta aggregates
    Clark, Gretchen T., Yu, Yanlei, Urban, Cooper A., Fu, Guo, Wang, Chunyu, Zhang, Fuming, Linhardt, Robert J., Hurley, Jennifer M. · 2022 · PLOS Genetics
21. Terpenes as Potential Anti-Alzheimer’s Disease Agents
    Elisabete Lima, Jorge Medeiros · 2024 · Applied Sciences
22. Class balancing diversity multimodal ensemble for Alzheimer’s disease diagnosis and early detection
    Francesconi, Arianna, di Biase, Lazzaro, Cappetta, Donato, Rebecchi, Fabio, Soda, Paolo, Sicilia, Rosa, Guarrasi, Valerio · 2025 · Computerized Medical Imaging and Graphics
23. A qualitative study of the impact of a dementia experiential learning project on pre-medical students: a friend for Rachel
    Jill S. Goldman, Amy Trommer · 2019 · BMC Medical Education
24. Impact of the Astaxanthin, Betanin, and EGCG Compounds on Small Oligomers of Amyloid Aβ40 Peptide
    Huynh Minh Hung, Minh Tho Nguyen, Phuong‐Thao Tran, Vi Khanh Truong, James Chapman, Huu Quynh Anh Lê, Philippe Derreumaux, Van V. Vu, Sơn Tùng Ngô · 2020 · Journal of Chemical Information and Modeling
25. Neuropsychiatric symptom profiles of community‐dwelling persons living with dementia: Factor structures revisited
    Natalie G. Regier, Nancy A. Hodgson, Laura N. Gitlin · 2020 · International Journal of Geriatric Psychiatry
26. Pre-Diabetes, but not Type 2 Diabetes, Is Related to Brain Amyloid in Late Middle-Age
    Jose Alejandro Luchsinger, Priya Palta, Brady Rippon, Greysi Sherwood, Luisa Soto, Fernando Ceballos, Krystal K. Laing, Kay Chioma Igwe, Hengda He, Qolamreza Ray Razlighi et al. · 2020 · Journal of Alzheimer s Disease
27. Dietary Interventions to Prevent or Delay Alzheimer’s Disease: What the Evidence Shows
    Zachary Bartochowski, Joseph Conway, Yisrael Wallach, Binu Chakkamparambil, Suraj Alakkassery, George Thomas Grossberg · 2020 · Current Nutrition Reports
28. MicroRNA-Based Multitarget Approach for Alzheimer’s Disease: Discovery of the First-In-Class Dual Inhibitor of Acetylcholinesterase and MicroRNA-15b Biogenesis
    Moustafa Tarek Gabr, Simone Brogi · 2020 · Journal of Medicinal Chemistry
29. Neurodegenerative changes in early- and late-onset cognitive impairment with and without brain amyloidosis
    Eddie Stage, Diana Otero Svaldi, Meredith Lois Phillips, Victor Hugo Canela, Tuğçe Duran, Naira Goukasian, Shannon L. Risacher, Andrew J. Saykin, Liana G. Apostolova, Alzheimer’s Disease Neuroimaging Initiative · 2020 · Alzheimer s Research & Therapy
30. A dyadic perspective on assessment in Alzheimer's dementia: Supporting both care partners across the disease continuum
    Silvia Orsulic‐Jeras, Carol J. Whitlatch, Sara M. Powers, Justin D. Johnson · 2020 · Alzheimer s & Dementia Translational Research & Clinical Interventions
31. Classification among healthy, mild cognitive impairment and Alzheimer’s disease subjects based on wavelet entropy and relative beta and theta power
    Jorge Esteban Santos Toural, Arquímedes Montoya Pedrón, Enrique Juan Marañón Reyes · 2020 · Pattern Analysis and Applications
32. Deep neural network models for identifying incident dementia using claims and EHR datasets
    Vijay S. Nori, Christopher A. Hane, Yezhou Sun, William H. Crown, Paul A. Bleicher · 2020 · PLoS ONE
33. Alzheimer’s disease: a tale of two diseases?
    Eleonora Nardini, Ryan Hogan, Anthony Flamier, Gilbert Bernier · 2021 · Neural Regeneration Research
34. Pharmacist-Physician Interprofessional Collaboration to Promote Early Detection of Cognitive Impairment: Increasing Diagnosis Rate
    Hernán Ramos, Juan Pardo, Rafael Madariaga Sánchez, Esteve Puchades, Jordi Pérez‐Tur, Andrés Navarro‐Ruiz, Lucrecia Moreno · 2021 · Frontiers in Pharmacology
35. Hydrogen Sulfide Ameliorates Lipopolysaccharide-Induced Memory Impairment in Mice by Reducing Apoptosis, Oxidative, and Inflammatory Effects
    Viplav Vitthal Kshirsagar, Chetan Thingore, Malvika Gursahani, Nitin Bhanudas Gawali, Archana Ramesh Juvekar · 2021 · Neurotoxicity Research
36. Caring for Relatives with Dementia in Times of COVID-19: Impact on Caregivers and Care-recipients
    Andrés Losada‐Baltar, Carlos Vara‐García, Rosa Romero‐Moreno, Samara Barrera‐Caballero, María del Sequeros Pedroso‐Chaparro, Lucía Jiménez‐Gonzalo, José Fernándes-Pires, Isabel Cabrera, Laura Gallego‐Alberto, Cristina Huertas‐Domingo et al. · 2021 · Clinical Gerontologist
37. Fecal Microbiota Transplantation: A Microbiome Modulation Technique for Alzheimer’s Disease
    Varsha Nandwana, Shibajee Debbarma · 2021 · Cureus
38. Multimodal Prediction of Alzheimer's Disease Severity Level Based on Resting-State EEG and Structural MRI
    Belmir J. de Jesus, Raymundo Cassani, William Jonathan McGeown, Marco Cecchi, K.C. Fadem, Tiago Henrique Falk · 2021 · Frontiers in Human Neuroscience
39. Probiotics as potential therapeutic options for Alzheimer’s disease
    Hong‐Fang Ji, Liang Shen · 2021 · Applied Microbiology and Biotechnology
40. The impacts of health insurance and resource on the burden of Alzheimer's disease and related dementias in the world population
    Jintao Wang, Gang Xu, Ru‐Jing Ren, Ying Wang, Ran Tang, Qiang Huang, Jianping Li, Murad Al‐Nusaif, Weidong Le, Gang Wang · 2022 · Alzheimer s & Dementia
41. Pathogenesis of Alzheimer’s Disease and Diversity of 1,2,3-Triazole Scaffold in Drug Development: Design Strategies, Structural Insights, and Therapeutic Potential
    Atamjit Singh, Karanvir Singh, Jashandeep Kaur, Ramanpreet Kaur, Aman Sharma, Jasleen Kaur, Uttam Kaur, Renu Chadha, Preet Mohinder Singh Bedi · 2023 · ACS Chemical Neuroscience
42. Alzheimer Disease: Recent Updates on Apolipoprotein E and Gut Microbiome Mediation of Oxidative Stress, and Prospective Interventional Agents
    Botchway, Benson OA, Okoye, Favour C, Chen, Yili, Arthur, William E, Fang, Marong · 2022 · Aging and disease
43. Multi-Template Meta-Information Regularized Network for Alzheimer’s Disease Diagnosis Using Structural MRI
    Kangfu Han, Gang Li, Zhiwen Fang, Feng Yang · 2023 · IEEE Transactions on Medical Imaging
44. Trends in prevalence, mortality, and risk factors of dementia among the oldest-old adults in the United States: the role of the obesity epidemic
    Xueshan Cao, Minmin Wang, Mengge Zhou, Yuanqi Mi, Vince Fazekas‐Pongor, Dávid Major, Andrea Lehoczki, Yang Guo · 2024 · GeroScience
45. The Role of Glial Fibrillary Acidic Protein in the Neuropathology of Alzheimer’s Disease and Its Potential as a Blood Biomarker for Early Diagnosis and Progression
    E.M.S. Bandara, Prita Riana Asih, Steve Pedrini, Eugene Hone, Warnakulasuriya Mary Ann Dipika Binosha Fernando, Ralph Nigel Martins · 2025 · Molecular Neurobiology
46. Type 2 Diabetes Interacts With Alzheimer Disease Risk Factors to Predict Functional Decline
    Kelsey R. Thomas, Katherine J. Bangen, Alexandra J. Weigand, Emily C. Edmonds, Erin E. Sundermann, Christina G. Wong, Joel S. Eppig, Madeleine L. Werhane, Lisa Delano‐Wood, Mark William Bondi · 2019 · Alzheimer Disease & Associated Disorders
47. Modification of Aβ Peptide Aggregation via Covalent Binding of a Series of Ru(III) Complexes
    Luiza Moreira Gomes, Janaina C. Bataglioli, Allison J. Jussila, Jason R. Smith, Charles J. Walsby, Tim Storr · 2019 · Frontiers in Chemistry
48. Mitochondrial Calcium Signaling as a Therapeutic Target for Alzheimer’s Disease
    Aston Jiaxi Wu, Benjamin Chun‐Kit Tong, Shiying Huang, Min Li, King‐Ho Cheung · 2019 · Current Alzheimer Research
49. US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer’s Disease: Implications for Global Drug Development
    Anne Vinther Morant, Henrik Tang Vestergaard, Anders Blædel Lassen, V. Navikas · 2020 · Clinical and Translational Science
50. Calorimetric Studies of Binary and Ternary Molecular Interactions between Transthyretin, Aβ Peptides, and Small-Molecule Chaperones toward an Alternative Strategy for Alzheimer’s Disease Drug Discovery
    Ellen Y. Cotrina, Ana Gimeno, Jordi Llop, Jesús Jiménez‐Barbero, Jordi R. Quintana, Gregorio Valencia, Isabel Cardoso, Rafel Prohens, Gemma Arsequell · 2020 · Journal of Medicinal Chemistry
51. A human induced pluripotent stem cell‐derived cortical neuron human‐on‐a chip system to study Aβ 42 and tau‐induced pathophysiological effects on long‐term potentiation
    Julbert Caneus, Nesar Akanda, John W. Rumsey, Xiufang Guo, Max Jackson, Christopher J. Long, Frank Sommerhage, Sanya Georgieva, Nicholas M. Kanaan, David Morgan et al. · 2020 · Alzheimer s & Dementia Translational Research & Clinical Interventions
52. Virtual reality and dementia: A bibliometric analysis
    Margarida Sobral, Maria Helena de Aguiar Pereira e Pestana · 2020 · The European Journal of Psychiatry
53. Metallic Woodpile Nanostructures for Femtomolar Sensing of Alzheimer’s Neurofilament Lights
    Kayoung Kim, Gyu Rac Lee, Moohyun Kim, Hunhee Lim, Yeon Sik Jung, Chan Beum Park · 2020 · ACS Nano
54. Dominantly inherited Alzheimer's disease in Latin America: Genetic heterogeneity and clinical phenotypes
    Jorge J. Llibre‐Guerra, Yan Li, Ricardo Allegri, Patricio Chrem Méndez, Ezequiel Ignacio Surace, Juan J. Llibre Rodríguez, Ana Luisa Sosa, Carmen Aláez‐Verson, Erika Mariana Longoria-Ibarrola, José Alberto Téllez‐Martínez et al. · 2020 · Alzheimer s & Dementia
55. Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer’s Disease Agents
    Viviana Poliseno, Sı́lvia Chaves, Leonardo Brunetti, Fulvio Loiodice, Antonio Carrieri, Antonio Laghezza, Paolo Tortorella, João Duarte Magalhães, Sandra M. Cardoso, Maria Amélia Santos et al. · 2021 · Biomolecules
56. The protective effect of Indian Catechu methanolic extract against aluminum chloride-induced neurotoxicity, A rodent model of Alzheimer's disease
    Ekramy Mahmoud Elmorsy, Eman Ramadan Elsharkawy, Fahad Abdulrahman Alhumaydhi, Mohamed Salama · 2021 · Heliyon
57. Simultaneous modeling of Alzheimer's disease progression via multiple cognitive scales
    Line Kühnel, Anna‐Karin Berger, Bo Markussen, Lars Lau Rakêt · 2021 · Statistics in Medicine
58. A Modified Convolutional Neural Networks For MRI-based Images For Detection and Stage Classification Of Alzheimer Disease
    Majdah Alshammari, Mohammad A. Mezher · 2021 · National Computing Colleges Conference (NCCC)
59. The Longitudinal Association of Vision Impairment With Transitions to Cognitive Impairment and Dementia: Findings From the Aging, Demographics and Memory Study
    Joshua R. Ehrlich, Bonnielin K. Swenor, Yunshu Zhou, Kenneth M. Langa · 2021 · The Journals of Gerontology Series A
60. Improved quality of care and reduced healthcare costs at the end-of-life among older people with dementia who received palliative home care: A nationwide propensity score-matched decedent cohort study
    Rose Miranda, Tinne Smets, Robrecht De Schreye, Kristof Faes, Nele Van Den Noortgate, Joachim Cohen, Lieve Van den Block · 2021 · Palliative Medicine
61. The “Counseling+” Roles of the Speech-Language Pathologist Serving Older Adults With Mild Cognitive Impairment and Dementia From Alzheimer's Disease
    Alyssa M. Lanzi, James M. Ellison, Matthew L. Cohen · 2021 · Perspectives of the ASHA Special Interest Groups
62. Structural and mechanistic insights into amyloid‐β and α‐synuclein fibril formation and polyphenol inhibitor efficacy in phospholipid bilayers
    Henry M. Sanders, Blagojce Jovcevski‬, Michael Thomas Marty, Tara Louise Pukala · 2021 · FEBS Journal
63. The United States should recognize and support caregiving youth
    Emma Armstrong‐Carter, Catherine Johnson, Julia Belkowitz, Connie Siskowski, Elizabeth A. Olson · 2021 · Child Policy Nexus
64. Near-infrared target enhanced peripheral clearance of amyloid-β in Alzheimer's disease model
    Mengmeng Ma, Zhenqi Liu, Nan Gao, Kai Dong, Zifeng Pi, Lihua Kang, Xiubo Du, Jinsong Ren, Xiaogang Qu · 2021 · Biomaterials
65. Identification of Novel Cathepsin B Inhibitors with Implications in Alzheimer’s Disease: Computational Refining and Biochemical Evaluation
    Nitin Chitranshi, Ashutosh Kumar, Samran Sheriff, Veer Bala Gupta, Angela Godinez, Danit Saks, Soumalya Sarkar, Ting Shen, Mehdi Mirzaei, Devaraj K. Basavarajappa et al. · 2021 · Cells
66. Multi-view prediction of Alzheimer's disease progression with end-to-end integrated framework
    Yan Zhao, Bao-Qiang Ma, Tong-Tong Che, Qiong-Ling Li, Debin Zeng, Xuetong Wang, Shu-Yu Li · 2021 · Journal of Biomedical Informatics
67. Association of Nursing Home Organizational Culture and Staff Perspectives With Variability in Advanced Dementia Care
    Ruth Palan Lopez, Meghan Hendricksen, Ellen P. McCarthy, Kathleen M. Mazor, Ashley Roach, Anita Hendrix Rogers, Fayron R. Epps, Kimberly S. Johnson, Harriet Akunor, Susan L. Mitchell · 2022 · JAMA Internal Medicine
68. Technological Solutions for Diagnosis, Management and Treatment of Alzheimer’s Disease-Related Symptoms: A Structured Review of the Recent Scientific Literature
    Davide Maria Cammisuli, Gabriele Cipriani, Gianluca Castelnuovo · 2022 · International Journal of Environmental Research and Public Health
69. Detection of Alzheimer’s Dementia by Using Signal Decomposition and Machine Learning Methods
    Özlem Karabiber Cura, Aydın Akan, Gülce Coşku YILMAZ, Hatice Sabiha Türe · 2022 · International Journal of Neural Systems
70. Music‐based interventions for community‐dwelling people with dementia: A systematic review
    Lena Maria Hofbauer, Sabrina D. Ross, Francisca Saveria Rodriguez · 2022 · Health & Social Care in the Community
71. Graph Embedded Ensemble Deep Randomized Network for Diagnosis of Alzheimer's Disease
    A. K. Malik, M. Tanveer · 2022 · IEEE Transactions on Computational Biology and Bioinformatics
72. “Care for Me, Too”: A Novel Framework for Improved Communication and Support Between Dementia Caregivers and the Home Health Care Team
    Julia G. Burgdorf, Jennifer M. Reckrey, David Russell · 2022 · The Gerontologist
73. Pathophysiological Association of Alzheimer’s Disease and Hypertension: A Clinical Concern for Elderly Population
    Qianqian Yao, Kexin Jiang, Fei Lin, Tao Zhu, Nazeer Hussain Khan, Enshe Jiang · 2023 · Clinical Interventions in Aging
74. Deep Learning Based Multimodal Progression Modeling for Alzheimer’s Disease
    Yang, Liuqing, Wang, Xifeng, Guo, Qi, Gladstein, Scott, Wooten, Dustin, Li, Tengfei, Robieson, Weining Z, Sun, Yan, Huang, Xin, for the Alzheimer’s Disease Neuroimaging Initiative · 2021 · Statistics in Biopharmaceutical Research
75. β-Amyloid targeting nanodrug for neuron-specific delivery of nucleic acids in Alzheimer's disease mouse models
    Liron Limor Israel, Tao Sun, Oliver Braubach, Alysia Cox, Ekaterina S. Shatalova, Harun-Mohammad Rashid, Anna Galstyan, Zachary B. Grodzinski, Xue Ying Song, Oksana M. Chepurna et al. · 2023 · Journal of Controlled Release
76. Association of Egg Intake With Alzheimer’s Dementia Risk in Older Adults: The Rush Memory and Aging Project
    Yongyi Pan, Taylor C. Wallace, Tasija A Karosas, David Alan Bennett, Puja Agarwal, Mei Chun Chung · 2024 · Journal of Nutrition
77. Low testosterone levels relate to poorer cognitive function in women in an APOE-ε4-dependant manner
    Melanie A Dratva, Sarah Jane Banks, Matthew S. Panizzon, Douglas R Galasko, Erin E. Sundermann, Alzheimer’s Disease Neuroimaging Initiative · 2024 · Biology of Sex Differences
78. Sex Differences in the Neural Correlates of Spatial Context Memory Decline in Healthy Aging
    Sivaniya Subramaniapillai, Sricharana Rajagopal, Abdelhalim Elshiekh, Stamatoula Pasvanis, Elizabeth Ankudowich, Maria Natasha Rajah · 2019 · Journal of Cognitive Neuroscience
79. Nutritional and Functional Indicators and Their Association With Mortality Among Older Adults With Alzheimer’s Disease
    Odete Vicente de Sousa, Joana Mendes, Teresa Freitas do Amaral · 2020 · American Journal of Alzheimer s Disease & Other Dementias®
80. On the horizon—the value and promise of the global pipeline of Alzheimer's disease therapeutics
    Michael Cole, Guy R. Seabrook · 2020 · Alzheimer s & Dementia Translational Research & Clinical Interventions
81. Cohort discovery and risk stratification for Alzheimer's disease: an electronic health record‐based approach
    Donna Tjandra, Raymond Q. Migrino, Bruno Giordani, Jenna Wiens · 2020 · Alzheimer s & Dementia Translational Research & Clinical Interventions
82. Exploring dementia family caregivers’ everyday use and appraisal of technological supports
    Laura Block, Andrea L Gilmore‐Bykovskyi, Anna F. Jolliff, Shannon L. Mullen, Nicole E. Werner · 2020 · Geriatric Nursing
83. Inclusion of African American/Black adults in a pilot brain proteomics study of Alzheimer's disease
    Kaitlyn E. Stepler, Emily R. Mahoney, Julia Kofler, Timothy J. Hohman, Oscar L. López, Renã A. S. Robinson · 2020 · Neurobiology of Disease
84. Spiritual Fitness: A New Dimension in Alzheimer’s Disease Prevention
    Dharma Singh Khalsa, Andrew B. Newberg · 2021 · Journal of Alzheimer s Disease
85. Long runs of homozygosity are associated with Alzheimer’s disease
    Sonia Moreno–Grau, María Victoria Fernández, Itziar de Rojas, Pablo García‐González, Isabel Hernández, Fabiana Geraldo Farias, John Budde, Inés Quintela, Laura Madrid, Antonio González‐Pérez et al. · 2021 · Translational Psychiatry
86. Association between cognitive health and masticatory conditions: a descriptive study of the national database of the universal healthcare system in Japan
    John Daren Da Silva, Shy Chwen Ni, Cliff Lee, Hawazin W. Elani, Kailing Ho, Carlos Thomas, Yukinori Kuwajima, Yoshiki Ishida, Takuya Kobayashi, Shigemi Ishikawa‐Nagai · 2021 · Aging
87. What Can Economics Say about Alzheimer’s Disease?
    Amitabh Chandra, Courtney Coile, Corina Mommaerts · 2023 · Journal of Economic Literature
88. Unravelling the potential neuroprotective facets of erythropoietin for the treatment of Alzheimer’s disease
    Dapinder Kaur, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Vishnu Nayak Badavath, Syed Shams ul Hassan, Mohammad Mehedi Hasan, Saurabh Bhatia, Ahmed Al-Harassi et al. · 2021 · Metabolic Brain Disease
89. Unbalanced Regulation of α7 nAChRs by Ly6h and NACHO Contributes to Neurotoxicity in Alzheimer's Disease
    Meilin Wu, Clifford Z. Liu, Erika A. Barrall, Robert A. Rissman, William J. Joiner · 2021 · Journal of Neuroscience
90. Blood–Brain Barrier Permeable and NO-Releasing Multifunctional Nanoparticles for Alzheimer’s Disease Treatment: Targeting NO/cGMP/CREB Signaling Pathways
    Zhikun Liu, Qingqing Liu, Bin Zhang, Qiao Liu, Lei Fang, Shaohua Gou · 2021 · Journal of Medicinal Chemistry
91. An Evaluation of the Effects of Active Game Play on Cognition, Quality of Life and Depression for Older People with Dementia
    Jiaying Zheng, Ping Yu, Xueping Chen · 2021 · Clinical Gerontologist
92. Effectiveness and acceptability of non-pharmacological interventions in people with mild cognitive impairment: Overview of systematic reviews and network meta-analysis
    Mingyue Hu, Hengyu Hu, Zhanfang Shao, Yinyan Gao, Xianmei Zeng, Xinhui Shu, Jundan Huang, Shanshan Shen, Xinyin Wu, Lily Dongxia Xiao et al. · 2022 · Journal of Affective Disorders
93. The role of adenosine A2A receptors in Alzheimer's disease and tauopathies
    Agathe Launay, Ouada Nebie, Jhenkruthi Vijaya Shankara, Thibaud Lebouvier, Luc Buée, Émilie Faivre, David L Blum · 2022 · Neuropharmacology
94. Risk Prediction of Alzheimer’s Disease Conversion in Mild Cognitive Impaired Population Based on Brain Age Estimation
    Weijia Liu, Qunxi Dong, Shuting Sun, Jian Guo Shen, Kun Qian, Bin Hu · 2023 · IEEE Transactions on Neural Systems and Rehabilitation Engineering
95. Beyond Vision: A View from Eye to Alzheimer's Disease and Dementia
    Chuchu Zheng, Ruijie Zeng, Guohao Wu, Yijun Hu, Huiling Yu · 2023 · The Journal of Prevention of Alzheimer s Disease
96. Possible neuromodulating role of different grape (Vitis vinifera L.) derived polyphenols against Alzheimer’s dementia: treatment and mechanisms
    Ghadha Ibrahim Fouad, Maha Z. Rizk · 2019 · Bulletin of the National Research Centre/Bulletin of the National Research Center
97. Transformer-Based Multimodal Fusion for Early Diagnosis of Alzheimer's Disease Using Structural MRI And PET
    Yuanwang Zhang, Kaicong Sun, Yuxiao Liu, Dinggang G. Shen · 2023 · IEEE International Symposium on Biomedical Imaging (ISBI)
98. A scoping review of mathematical models covering Alzheimer's disease progression
    Seyedadel Moravveji, Nicolas Doyon, Javad Mashreghi, Simon Duchesne · 2024 · Frontiers in Neuroinformatics
99. Exploring the global impact of obesity and diet on dementia burden: the role of national policies and sex differences
    Xueshan Cao, Huiyuan Peng, Ziyi Hu, Chang Xu, Monan Ning, Mengge Zhou, Yuanqi Mi, Peipei Yu, Vince Fazekas‐Pongor, Dávid Major et al. · 2024 · GeroScience
100. Determinants of dementia diagnosis in U.S. primary care in the past decade: A scoping review
     Chelsea G. Cox, Barbara L. Brush, Lindsay C. Kobayashi, Jeffrey Scott Roberts · 2025 · The Journal of Prevention of Alzheimer s Disease